Isabelle Schrauwen

Title: The Innovative Contributions of Isabelle Schrauwen

Introduction

Isabelle Schrauwen is a prominent inventor based in Phoenix, AZ (US). She has made significant strides in the field of neuroscience, particularly through her innovative research and patent contributions. Her work focuses on the stimulation of microglia, which plays a crucial role in the brain's immune response.

Latest Patents

Isabelle Schrauwen holds a patent titled "TREM2 agonists for the stimulation of microglia and methods of identification." This patent is directed towards methods of promoting phagocytosis, specifically enhancing the phagocytic activity of microglia via the activation of triggering receptor expressed on myeloid cells 2 (TREM2). The patent also outlines methods for activating TREM2 in neuronal cells that exhibit an accumulation of pathogenic proteins. Additionally, it includes techniques for detecting the effects of compounds on TREM2 activity.

Career Highlights

Isabelle Schrauwen is affiliated with the Translational Genomics Research Institute, where she conducts her research. Her work has contributed to a deeper understanding of microglial function and its implications for neurodegenerative diseases. With her innovative approach, she has positioned herself as a key figure in her field.

Collaborations

Isabelle collaborates with notable colleagues, including Matthew Huentelman and Wayne Jepsen. Their combined expertise enhances the research efforts at the Translational Genomics Research Institute.

Conclusion

Isabelle Schrauwen's contributions to neuroscience through her patent and research are invaluable. Her work not only advances scientific knowledge but also holds potential for therapeutic applications in neurodegenerative diseases.